The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Open accessAbstract
BACKGROUND: Despite best current therapy, up to 20% of pediatric patients with acute lymphoblastic leukemia (ALL) have a relapse. Recent genomewide analyses have identified a high frequency of DNA copy-number abnormalities in ALL, but the prognostic implications of these abnormalities have not been defined. METHODS: We studied a cohort of 221 children with high-risk B-cell-progenitor ALL with the use of single-nucleotide-polymorphism microarrays, transcriptional profiling, and resequencing of samples obtained at diagnosis. Children with known very-high-risk ALL subtypes (i.e., BCR-ABL1-positive ALL, hypodiploid ALL, and ALL in infants) were excluded from this cohort. A copy-number abnormality was identified as a predictor of poor outcome, and it was then tested in an independent validation cohort of 258 patients with B-cell-progenitor ALL. RESULTS: More than 50 recurring copy-number abnormalities were identified, most commonly involving genes that encode regulators of B-cell development (in 66.8% of patients in the original cohort); PAX5 was involved in 31.7% and IKZF1 in 28.6% of patients. Using copy-number abnormalities, we identified a predictor of poor outcome that was validated in the independent validation cohort. This predictor was strongly associated with alteration of IKZF1, a gene that encodes the lymphoid transcription factor IKAROS. The gene-expression signature of the group of patients with a poor outcome revealed increased expression of hematopoietic stem-cell genes and reduced expression of B-cell-lineage genes, and it was similar to the signature of BCR-ABL1-positive ALL, another high-risk subtype of ALL with a high frequency of IKZF1 deletion. CONCLUSIONS: Genetic alteration of IKZF1 is associated with a very poor outcome in B-cell-progenitor ALL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mice, both Ikzf1 and Ikzf3 are required for normal T cell development and maintenance of mature T cell populations88,89”
From Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide (2021) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan‐Smith, E., Dalton, J., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,777
Self-citationPui, C.-H., Robison, L. L., & Look, A. T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60457-2 · Cited by 1,564
Self-citationBCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072
Self-citationThe ikaros gene is required for the development of all lymphoid lineages
Georgopoulos, K., Bigby, M., Wang, J.-H., Molnar, A., Wu, P., Winandy, S., & Sharpe, A. (1994) · Cell · doi:10.1016/0092-8674(94)90407-3 · Cited by 985
Borowitz, M. J., Devidas, M., Hunger, S. P., Bowman, W. P., Carroll, A. J., Carroll, W. L., Linda, S. B., Martin, P. L., Pullen, D. J., Viswanatha, D. S., et al. (2008) · Blood · doi:10.1182/blood-2008-01-132837 · Cited by 841
Self-citationPrediction by Supervised Principal Components
Bair, E., Hastie, T. J., Paul, D., & Tibshirani, R. J. (2006) · Journal of the American Statistical Association · doi:10.1198/016214505000000628 · Cited by 824
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., Shurtleff, S. A., & Downing, J. R. (2008) · Science · doi:10.1126/science.1164266 · Cited by 806
Self-citationOn testing the significance of sets of genes
Efron, B., & Tibshirani, R. J. (2007) · The Annals of Applied Statistics · doi:10.1214/07-aoas101 · Cited by 785
Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data
Bair, E., & Tibshirani, R. J. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020108 · Cited by 749
Flagged first, then by citations
Research works printed but not linked: 3
- Shuster JJ, 1999, Cancer Res Ther Control, 9, 101
- Pui CH, 2006, Ann Hematol, 85, 88
- Mirebeau D, 2006, Haematologica, 91, 881
Cited by
Sorted by citations
Items 601–700 of 1,000
Bacher, U., Kohlmann, A., & Haferlach, T. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.05.002 · Cited by 21
New frontiers in pediatric Allo-SCT: novel approaches for children and adolescents with ALL
Pulsipher, M. A., Wayne, A. S., & Schultz, K. R. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.114 · Cited by 20
Comparison of Feature Selection Methods for Cross-Laboratory Microarray Analysis
Liu, H., Peng, P.-C., Hsieh, T., Yeh, T., Lin, C., Chen, C., Hou, J., Shih, L., & Liang, D. (2013) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2013.70 · Cited by 21
Cell cycle‐specific function of Ikaros in human leukemia
Li, Z., Song, C., Ouyang, H., Lai, L., Payne, K. J., & Dovat, S. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23406 · Cited by 20
Unnikrishnan, A., Guan, Y. F., Huang, Y., Beck, D., Thoms, J. A. I., Peirs, S., Knezevic, K., Ma, S., de Walle, I. V., de Jong, I., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw804 · Cited by 20
Vu, T., Straube, J., Porter, A. H., Bywater, M. J., Song, A., Ling, V., Cooper, L. T., Pali, G., Bruedigam, C., Jacquelin, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16840-2 · Cited by 20
Efficacy of ruxolitinib in acute lymphoblastic leukemia: A systematic review
Kołodrubiec, J., Kozłowska, M., Irga‐Jaworska, N., Sędek, Ł., Pastorczak, A. K., Trelińska, J., & Mlynarski, W. M. (2022) · Leukemia Research · doi:10.1016/j.leukres.2022.106925 · Cited by 21
Lee, R. D., Knutson, T. P., Munro, S. A., Miller, J. T., Heltemes-Harris, L. M., Mullighan, C. G., Jepsen, K., & Farrar, M. A. (2022) · Nature Immunology · doi:10.1038/s41590-022-01343-7 · Cited by 20
Self-citationRegulatory Phosphorylation of Ikaros by Bruton's Tyrosine Kinase
Ma, H., Qazi, S., Özer, Z., Zhang, J., Ishkhanian, R., & Uckun, F. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071302 · Cited by 20
Self-citationA genomic random interval model for statistical analysis of genomic lesion data
Pounds, S. B., Cheng, C., Li, S., Liu, Z., Zhang, J., & Mullighan, C. G. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt372 · Cited by 20
Self-citationTremblay, C. S., Hoàng, T., & Hoang, T. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)92006-1 · Cited by 20
Andersson, A., Moorman, A. V., Harrison, C. J., & Mullighan, C. G. (2016) · Wiley eBooks · doi:10.1002/9781118527948.ch5 · Cited by 20
Self-citationAnaya, D. M., Moreno-Lorenzana, D., Reyes-León, A., Juárez, U., Dean, M. C., Aguilar-Hernández, M., Rivera-Sanchez, N., García-Islas, J., Vieyra-Fuentes, V., Zapata‐Tarrés, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179587 · Cited by 19
Genetic Targets in Pediatric Acute Lymphoblastic Leukemia
Gowda, C. S., & Dovat, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6176-0_15 · Cited by 19
Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia
Lana, T., Lorenzo, P. D., Bresolin, S., Bronzini, I., den Boer, M. L., Cavé, H., Froňková, E., Stanulla, M., Zaliova, M. K., Harrison, C. J., et al. (2015) · Leukemia · doi:10.1038/leu.2015.78 · Cited by 19
Ninomiya, S., Tyybäkinoja, A., Borze, I., Räty, R., Saarinen‐Pihkala, U. M., Usvasalo, A., Elonen, E., & Knuutila, S. (2012) · Cytogenetic and Genome Research · doi:10.1159/000337297 · Cited by 19
2016 Revision to the WHO classification of acute lymphoblastic leukemia
Wang, S., & He, G. (2016) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2016-0040 · Cited by 19
How is the Ph-like signature being incorporated into ALL therapy?
Maese, L. D., Tasian, S. K., & Raetz, E. A. (2017) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2017.06.001 · Cited by 19
Al-absi, B., Razif, M. F. M., Noor, S. M., Saif-Ali, R., Aqlan, M., Salem, S. D., Ahmed, R. H., & Muniandy, S. (2017) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2017.0084 · Cited by 19
Wolach, O., Amitai, I., & DeAngelo, D. J. (2017) · British Journal of Haematology · doi:10.1111/bjh.14916 · Cited by 20
Fakih, R. O. E., Savani, B. N., Mohty, M., & Aljurf, M. D. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.08.010 · Cited by 19
Gupta, S., Bakhshi, S., Kumar, L., Seth, R. K., & Kumar, R. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.07.010 · Cited by 19
Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia
Hütter, G., Kaiser, M., Neumann, M., Mossner, M., Nowak, D., Baldus, C. D., Gökbuget, N., Hoelzer, D. F., Thiel, E., & Hofmann, W. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.11.015 · Cited by 19
Ou, Z., Sherer, M. E., Casey, J., Bakos, H. A., Vitullo, K., Hu, J., Friehling, E. D., Gollin, S. M., Surti, U., & Yatsenko, S. A. (2016) · Cytogenetic and Genome Research · doi:10.1159/000456572 · Cited by 19
Grioni, A., Fazio, G., Rigamonti, S., Bystrý, V., Daniele, G., Dostálová, Z., Quadri, M., Saitta, C., Silvestri, D., Songia, S., et al. (2019) · HemaSphere · doi:10.1097/hs9.0000000000000250 · Cited by 19
Ramón-Vázquez, A., Flood, P. F., Cashman, T. L., Patil, P., & Ghosh, S. K. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103735 · Cited by 18
Gao, W., Huang, J., Deng, K., Lin, X., Long, X., Li, X., Huang, M., Wang, X., She, X., Liu, Q., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101329 · Cited by 18
Advances in the Biology of Acute Lymphoblastic Leukemia—From Genomics to the Clinic
Mullighan, C. G., & Willman, C. L. (2011) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2011.0012 · Cited by 18
Self-citationAcute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA Sequencing
Wang, J., Bhakta, N. H., Miller, V. A., Revsine, M., Litzow, M. R., Paietta, E. M., Fedoriw, Y., Roberts, K. G., Gu, Z., Mullighan, C. G., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00326 · Cited by 18
Self-citationGupta, S., Singh, M., Chandrashekar, P. H., Bakhshi, S., Trehan, A., Gupta, R., Thakur, R., Gajendra, S., Sharma, P., Sreedharanunni, S., et al. (2022) · HemaSphere · doi:10.1097/hs9.0000000000000782 · Cited by 18
Gupta, D. G., Varma, N., Sharma, P. R. N., Truica, M. I., Abdulkadir, S. A., Singh, P., Sachdeva, M. U. S., Naseem, S., Siddiqui, M. R., Bose, P. L., et al. (2023) · Cancer · doi:10.1002/cncr.34957 · Cited by 18
Usvasalo, A., Elonen, E., Saarinen‐Pihkala, U. M., Räty, R., Harila‐Saari, A. H., Koistinen, P., Savolainen, E., Knuutila, S., & Hollmén, J. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.02.031 · Cited by 18
Navigating Transcriptional Coregulator Ensembles to Establish Genetic Networks
DeVilbiss, A., Tanimura, N., McIver, S. C., Katsumura, K. R., Johnson, K. D., & Bresnick, E. H. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.01.003 · Cited by 20
Long noncoding RNAs in hematopoietic malignancies
Rodriguez-Malave, N. I., & Rao, D. S. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv047 · Cited by 19
Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia
Karol, S. E., & Pui, C. (2020) · Therapeutic Advances in Hematology · doi:10.1177/2040620720927575 · Cited by 18
Self-citationC/EBPβ induces B‐cell acute lymphoblastic leukemia and cooperates with BLNK mutations
Kurata, M., Onishi, I., Takahara, T., Yamazaki, Y., Ishibashi, S., Goitsuka, R., Kitamura, D., Takita, J., Hayashi, Y., Largaesapda, D. A., et al. (2021) · Cancer Science · doi:10.1111/cas.15164 · Cited by 19
Pui, C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.014 · Cited by 18
Self-citationPalmi, C., Lana, T., Silvestri, D., Savino, A. M., Kronnie, G. T., Conter, V., Basso, G., Biondi, A., Valsecchi, M. G., & Cazzaniga, G. (2013) · Haematologica · doi:10.3324/haematol.2013.099077 · Cited by 18
Behrens, K., Brajanovski, N., Xu, Z., Viney, E. M., DiRago, L., Hediyeh-zadeh, S., Davis, M. J., Pearson, R. B., Sanij, E., Alexander, W. S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj8803 · Cited by 17
Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer
Carey-Smith, S. L., Kotecha, R. S., Cheung, L. C., & Malinge, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136815 · Cited by 18
Wang’ondu, R. W., Ashcraft, E., Chang, T., Roberts, K. G., Brady, S. W., Fan, Y., Evans, W. E., Relling, M. V., Crews, K. R., Yang, J. J. J., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02633-3 · Cited by 17
Self-citationPeter, A., Heiden, T., Taube, T., Körner, G., & Seeger, K. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01315.x · Cited by 17
Rudant, J., Orsi, L., Bonaventure, A., Goujon, S., Corda, E., Baruchel, A., Bertrand, Y., Nelken, B., Robert, A., Michel, G., et al. (2012) · Leukemia · doi:10.1038/leu.2012.244 · Cited by 17
Recent advances in acute lymphoblastic leukemia in children and adolescents
Asselin, B. L., Gaynon, P. S., & Whitlock, J. A. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000017 · Cited by 17
Ikaros in hematopoiesis and leukemia
Dovat, S. (2011) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v2.i6.105 · Cited by 17
Prognostification of ALL by Cytogenetics
Hakeem, A., Shiekh, A. A., Bhat, G. M., & Lone, A. R. (2014) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-014-0483-0 · Cited by 17
Single Nucleotide Polymorphism Microarray Analysis of Genetic Alterations in Cancer
Mullighan, C. G. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-074-4_17 · Cited by 17
Self-citationOne missense mutation in exon 2 of the PAX5 gene in Iran
Yazdanparast, S. M., Khatami, S. R., Galehdari, H., & Jaseb, K. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.22.1 · Cited by 17
Role of stem cell transplant and maintenance therapy in plasma cell disorders
McCarthy, P. L., & Holstein, S. A. (2016) · Hematology · doi:10.1182/asheducation-2016.1.504 · Cited by 17
Mitchell, R. J., Kirkwood, A. A., Barretta, E., Clifton‐Hadley, L., Lawrie, E., Lee, S., Leongamornlert, D. A., Marks, D. I., McMillan, A., Menne, T., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004430 · Cited by 17
Nicholson, L., Evans, C. A., Matheson, E. C., Minto, L., Keilty, C., Sanichar, M., Case, M. C., Schwab, C. J., Williamson, D., Rainer, J., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13647 · Cited by 17
Pathobiology of acute lymphoblastic leukemia
Paolini, S., Gazzola, A., Sabattini, E., Bacci, F., Pileri, S. A., & Piccaluga, P. P. (2011) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2011.02.008 · Cited by 17
The Role of Dendritic Cells in Graft-Versus-Tumor Effect
Toubai, T., Mathewson, N. D., & Reddy, P. R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00066 · Cited by 17
Prognostic significance of the Musashi-2 (MSI2) gene in childhood acute lymphoblastic leukemia
Zhao, H., JIA, M., Luo, Z., CHENG, Y. P., Xu, X., ZHANG, J. Y., Li, S., & Tang, Y. (2015) · Neoplasma · doi:10.4149/neo_2016_018 · Cited by 17
Self-citationMeyer, J. A., Zhou, D., Mason, C. C., Downie, J. M., Rodic, V., Abromowitch, M., Wistinghausen, B., Termuhlen, A. M., Angiolillo, A. L., Perkins, S. L., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26363 · Cited by 17
Boulianne, B., Robinson, M. E., May, P. C., Castellano, L., Blighe, K., Thomas, J., Reid, A. G., Müschen, M., Apperley, J. F., Stebbing, J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.057 · Cited by 18
SH2B3: a new leukemia predisposition gene
Willman, C. L. (2013) · Blood · doi:10.1182/blood-2013-08-519843 · Cited by 17
Self-citationPax5 Haploinsufficiency Cooperates with BCR-ABL1 to Induce Acute Lymphoblastic Leukemia
Miller, C. B., Mullighan, C. G., Su, X., Ma, J., Wang, M., Zhang, J., Williams, R. T., & Downing, J. R. (2008) · Blood · doi:10.1182/blood.v112.11.293.293 · Cited by 17
Self-citationTumor suppression in T cell leukemia—The role of Ikaros
Dovat, S., & Payne, K. J. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.10.010 · Cited by 17
Molecular Biology of Childhood Leukemia
Alexander, T., & Mullighan, C. G. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-043020-110055 · Cited by 18
Self-citationThe clinical impact of IKZF1 mutation in acute myeloid leukemia
Zhang, X., Huang, A., Liu, L., Qin, J., Wang, C., Yang, M., Lou, Y., Wang, L., Ni, X., Hu, X., et al. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00398-y · Cited by 16
Acute lymphoblastic leukemia in young adults
McNeer, J. L., & Raetz, E. A. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835538f8 · Cited by 16
Therapies on the horizon for childhood acute lymphoblastic leukemia
Carroll, W. L., & Hunger, S. P. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000293 · Cited by 16
Self-citationGenomic analysis of adult B-ALL identifies potential markers of shorter survival
Patel, S. B., Mason, C. C., Glenn, M. J., Paxton, C. N., South, S. T., Cessna, M. H., Asch, J. D., Cobain, E. F., Bixby, D. L., Smith, L. B., et al. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.01.034 · Cited by 16
Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients
Jain, N., Lu, X. Y., Daver, N. G., Thakral, B., Wang, S. A., Konoplev, S. N., Patel, K. P., Kanagal‐Shamanna, R., Valentine, M. B., Tang, G., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.161000 · Cited by 16
Self-citationTranscribing malignancy: transcription-associated genomic instability in cancer
Boulianne, B., & Feldhahn, N. (2017) · Oncogene · doi:10.1038/onc.2017.402 · Cited by 17
Steeghs, E. M. P., Bakker, M., Hoogkamer, A. Q., Boer, J. M., Hartman, Q. J., Stalpers, F., Escherich, G., de Haas, V., de Groot‐Kruseman, H. A., Pieters, R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-17704-4 · Cited by 16
Aldoss, I. T., Kamal, M. O., Forman, S. J., & Pullarkat, V. A. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.09.041 · Cited by 16
Mahjoub, S., Chayeb, V. A., Zitouni, H., Ghali, R. M., Regaieg, H., Almawi, W. Y., & Mahjoub, T. (2019) · BMC Medical Genetics · doi:10.1186/s12881-019-0900-1 · Cited by 16
Płotka, A., & Lewandowski, K. C. (2021) · Acta Haematologica · doi:10.1159/000519782 · Cited by 16
Kiciński, M., Arfeuille, C., Grardel, N., Bakkus, M. H. C., Caye‐Eude, A., Plat, G., Ferster, A., Uyttebroeck, A., Moerloose, B. D., Rohrlich, P., et al. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.30313 · Cited by 16
Kawamura, M., Taki, T., Kaku, H., Ohki, K., & Hayashi, Y. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22251 · Cited by 16
TP53in adult acute lymphoblastic leukemia
Salmoiraghi, S., Rambaldi, A., & Spinelli, O. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1344839 · Cited by 18
The Utilization of Chromosomal Microarray Technologies for Hematologic Neoplasms
Peterson, J. F., Dyke, D. L. V., Hoppman, N. L., Kearney, H. M., Sukov, W. R., Greipp, P. T., Ketterling, R. P., & Baughn, L. B. (2018) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqy076 · Cited by 16
Lü, Y., Kham, S. K. Y., Ariffin, H., Oei, A. M. I., Lin, H. P., Tan, A. M., Quah, T. C., & Yeoh, A. E. J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.7 · Cited by 16
Heltemes-Harris, L. M., Hubbard, G. K., LaRue, R. S., Munro, S. A., Knutson, T. P., Yang, R., Henzler, C. M., Starr, T. K., Sarver, A. L., Kornblau, S. M., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02012-z · Cited by 15
Senapati, J., Jabbour, E. J., Konopleva, M. Y., Short, N. J., Tang, G., Daver, N. G., Kebriaei, P., Kadia, T. M., Pemmaraju, N., Takahashi, K., et al. (2023) · JCO Precision Oncology · doi:10.1200/po.22.00707 · Cited by 15
Self-citationMultifaceted roles of IKZF1 gene, perspectives from bench to bedside
Feng, L., Zhang, H., & Liu, T. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1383419 · Cited by 15
Boer, J. M., Koudijs, M. J., Kester, L. A., Sonneveld, E., Hehir‐Kwa, J. Y., Snijder, S., Waanders, E., Buijs, A., de Haas, V., van der Sluis, I. M., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-24-00788 · Cited by 15
Tonnelle, C., Dijon, M., Moreau, T., Garulli, C., Bardin, F., & Chabannon, C. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.004 · Cited by 15
Nowak, D., Klaumuenzer, M., Hanfstein, B., Mossner, M., Nolte, F., Nowak, V., Oblaender, J., Hecht, A., Hütter, G., Ogawa, S., et al. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.21961 · Cited by 15
Liu, P., Lin, Z.-K., Qian, S., Qiao, C., Qiu, H., Wu, Y., Li, J., & Ge, Z. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1415-4 · Cited by 15
Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
Chung, C., & Ma, H. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1977 · Cited by 16
Tang, S., Shen, H., Qu, C., Dai, H., Zhu, X., Xue, S., Ding, Z., Lu, J., Wu, D., & Tang, X. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0249-7 · Cited by 15
Yi, L., Hu, Q., Zhou, J., Liu, Z., & Li, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.064 · Cited by 15
Capria, S., Molica, M., Mohamed, S. F., Bianchi, S., Moleti, M. L., Trisolini, S. M., Chiaretti, S., & Testi, A. M. (2020) · Expert Review of Hematology · doi:10.1080/17474086.2020.1770591 · Cited by 15
Koschut, D., Ray, D., Li, Z., Giarin, E., Groet, J., Alić, I., Kham, S. K. Y., Chng, W. J., Ariffin, H., Weinstock, D. M., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01567-7 · Cited by 15
Αmpatzidou, Μ., Florentin, L., Papadakis, V., Paterakis, G. S., Tzanoudaki, M., Bouzarelou, D., Papadhimitriou, S. I., & Polychronopoulou, S. (2021) · Cancers · doi:10.3390/cancers13133289 · Cited by 15
Mangum, D. S., Meyer, J. A., Mason, C. C., Shams, S., Maese, L. D., Gardiner, J. D., Downie, J. M., Pei, D., Cheng, C., Gleason, A. G., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.2723 · Cited by 15
Self-citationRahman, Z. A., Heckman, M. G., Anagnostou, T., White, L. J., Kloft‐Nelson, S. M., Knudson, R. A., Alkhateeb, H. B., Sproat, L. Z., Khera, N., Murthy, H. S., et al. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00538-9 · Cited by 15
Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?
Tran, T. H., & Tasian, S. K. (2021) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2021.101331 · Cited by 15
Ikaros Proteins in Tumor: Current Perspectives and New Developments
Xia, R., Cheng, Y., Han, X., Wei, Y., & Wei, X. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.788440 · Cited by 17
Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents
Ne, E., Crespo, R., Izquierdo-Lara, R. W., Rao, S., Koçer, S., Górska, A., van Staveren, T., Kan, T. W., van de Vijver, D. A. M. C., Dekkers, D. H. W., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac407 · Cited by 15
Unusual PDGFRB fusion reveals novel mechanism of kinase activation in Ph-like B-ALL
Sadras, T., Jalud, F. B., Kosasih, H. J., Horne, C. R., Brown, L. M., El-Kamand, S., de Bock, C. E., Mcaloney, L., Ng, A. P., Davidson, N., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01843-x · Cited by 15
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
Eckardt, J., Stasik, S., Röllig, C., Petzold, A., Sauer, T., Scholl, S., Hochhaus, A., Crysandt, M. M., Brümmendorf, T. H., Naumann, R., et al. (2023) · Leukemia · doi:10.1038/s41375-023-02061-1 · Cited by 15
Recent Advances in the Understanding and Treatment of Pediatric Leukemias
Maloney, K. W., Giller, R., & Hunger, S. P. (2012) · Advances in Pediatrics · doi:10.1016/j.yapd.2012.04.010 · Cited by 15
Self-citationVasoactive intestinal peptide signaling axis in human leukemia
Dorsam, G. P. (2011) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v2.i6.146 · Cited by 15
Epidemiology, pathogenesis, and etiology of acute leukemia
Fiegl, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-26772-2_2 · Cited by 15
CD36-positive B-lymphoblasts Predict Poor Outcome in Children With B-lymphoblastic Leukemia
Newton, J. G., Horan, J., Newman, S., Rossi, M. R., Ketterling, R. P., & Park, S. I. (2017) · Pediatric and Developmental Pathology · doi:10.1177/1093526616688753 · Cited by 15
Singh, N., Tripathi, A. K., Sahu, D. K., Mishra, A., Linan, M. K., Argente, B., Varkey, J., Parida, N., Chowdhry, R., Shyam, H., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25752 · Cited by 15
Metadata
- Authors
- Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., Harvey, R. C., Chen, I.-M., Clifford, R. J., Carroll, W. L., Reaman, G., Bowman, W. P., Devidas, M., Gerhard, D. S., Yang, W., Relling, M. V., Shurtleff, S. A., Campana, D., Borowitz, M. J., Pui, C.-H., Smith, M., Hunger, S. P., Willman, C. L., & Downing, J. R.
- Affiliations
- St. Jude Children's Research Hospital (US)
- National Institutes of Health (US)
- UNM Comprehensive Cancer Center (US)
- New York University (US)
- Children's National (US)
- Cook Children's Medical Center (US)
- University of Florida Health (US)
- Children's Hospital Colorado (US)
- ORCID
- Mullighan, Charles G.
- Su, Xiaoping
- Zhang, Jinghui
- Radtke, Ina
- Ma, Jing
- Liu, Wei
- Cheng, Cheng
- Schulman, Brenda A.
- Harvey, Richard C.
- Chen, I-Ming
- Clifford, Robert J.
- Carroll, William L.
- Reaman, Gregory
- Bowman, W. Paul
- Devidas, Meenakshi
- Yang, Wenjian
- Relling, Mary V.
- Campana, Dario
- Pui, Ching-Hon
- Smith, Malcolm
- Hunger, Stephen P.
- Willman, Cheryl L.
- Downing, James R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-01-29
- Volume
- 360
- Issue
- 5
- Pages
- 470-480
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2674612
- OpenAlex
- W2040329520
- Cited by
- 1,422
- References
- 37
- Citations by year
- 2026: 30 · 2025: 50 · 2024: 66 · 2023: 90 · 2022: 66 · 2021: 103 · 2020: 92 · 2019: 69 · 2018: 74 · 2017: 105 · 2016: 96 · 2015: 101 · 2014: 84 · 2013: 90 · 2012: 98
- FWCI
- 101.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Public Health Service (N01C012400, 21765)
- National Cancer Institute (CA 098543, R01CA086011, U10CA098413, U01CA157937, R01 CA86011, U10CA098543, U01CA114762, CA114762, P30CA021765)
- National Institute of General Medical Sciences (U01 GM61393, U01GM061374, U01-GM-61374, U01GM061393)
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- IKZF1 deletion, acute lymphoblastic leukemia, pediatric leukemia, copy number abnormalities, prognosis, PAX5, Ikaros, B cell development, gene expression signatures, relapse
- MeSH terms
- B-Lymphocytes, Child, DNA Mutational Analysis, Genotype, Hematopoietic Stem Cells, Humans, Prognosis, Recurrence, Cohort Studies, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Trans-Activators, Gene Expression, Treatment Outcome, Gene Deletion, Drug Resistance, Neoplasm, Mutation, Missense, Gene Expression Profiling, Ikaros Transcription Factor, PAX5 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
